(2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide

C43H81NO9 — CID 15693322

IUPAC(2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide
SMILESCCCCCCCC/C=C\CCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)[C@H](O)CCCCCCCCCCCCC
InChIInChI=1S/C43H81NO9/c1-3-5-7-9-11-13-15-16-17-18-19-20-22-23-25-27-29-31-36(46)35(34-52-43-41(50)40(49)39(48)38(33-45)53-43)44-42(51)37(47)32-30-28-26-24-21-14-12-10-8-6-4-2/h16-17,29,31,35-41,43,45-50H,3-15,18-28,30,32-34H2,1-2H3,(H,44,51)/b17-16-,31-29+/t35-,36+,37+,38+,39+,40-,41+,43+/m0/s1
InChIKeyICZSQCPLHCQYTM-LRAKQQMQSA-N
MW756.12 g/mol
LogP7.30
Rot. Bonds35

About (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide

(2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide (PubChem CID 15693322) has the molecular formula C43H81NO9 and a molecular weight of 756.12 g/mol. Its IUPAC name is (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide.

Molecular Properties

Compound Name(2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide
PubChem CID15693322
Molecular FormulaC43H81NO9
Molecular Weight756.12 g/mol
Exact Mass755.59
IUPAC Name(2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide
SMILESCCCCCCCC/C=C\CCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)[C@H](O)CCCCCCCCCCCCC
InChIInChI=1S/C43H81NO9/c1-3-5-7-9-11-13-15-16-17-18-19-20-22-23-25-27-29-31-36(46)35(34-52-43-41(50)40(49)39(48)38(33-45)53-43)44-42(51)37(47)32-30-28-26-24-21-14-12-10-8-6-4-2/h16-17,29,31,35-41,43,45-50H,3-15,18-28,30,32-34H2,1-2H3,(H,44,51)/b17-16-,31-29+/t35-,36+,37+,38+,39+,40-,41+,43+/m0/s1
InChIKeyICZSQCPLHCQYTM-LRAKQQMQSA-N
XLogP7.30
TPSA168.94 Ų
H-Bond Donors7
H-Bond Acceptors9
Rotatable Bonds35
Heavy Atoms53
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500756.12
LogP ≤ 57.30
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide?
The IUPAC name of (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide (CID 15693322) is (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide.
What is the SMILES notation for (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide?
The canonical SMILES for (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide is CCCCCCCC/C=C\CCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)NC(=O)[C@H](O)CCCCCCCCCCCCC.
What is the InChIKey of (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide?
The InChIKey is ICZSQCPLHCQYTM-LRAKQQMQSA-N. The full InChI is InChI=1S/C43H81NO9/c1-3-5-7-9-11-13-15-16-17-18-19-20-22-23-25-27-29-31-36(46)35(34-52-43-41(50)40(49)39(48)38(33-45)53-43)44-42(51)37(47)32-30-28-26-24-21-14-12-10-8-6-4-2/h16-17,29,31,35-41,43,45-50H,3-15,18-28,30,32-34H2,1-2H3,(H,44,51)/b17-16-,31-29+/t35-,36+,37+,38+,39+,40-,41+,43+/m0/s1.
What are the key properties of (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide?
(2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide has a molecular weight of 756.12 g/mol, XLogP of 7.30, 35 rotatable bonds, 7 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-hydroxy-N-[(2S,3R,4E,13Z)-3-hydroxy-1-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxydocosa-4,13-dien-2-yl]pentadecanamide is sourced from PubChem (CID 15693322), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).